SSA
RPTX

Schonfeld Strategic Advisors’s Repare Therapeutics RPTX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio RPTX Stock Details RPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-21,200
Closed -$728K – 2076
2020
Q4 		$728K Buy
+21,200
New +$633K 0.01% 913

Other funds holding RPTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Schonfeld Strategic Advisors's RPTX Position: Q1 2021 in Review

Schonfeld Strategic Advisors sold out of Repare Therapeutics (RPTX) in Q1 2021, closing a stake of 21,200 shares — an estimated $728K sold.

Schonfeld Strategic Advisors first reported a position in RPTX in Q4 2020 and held it in 1 quarter. The position peaked at $728K in Q4 2020. 65 funds tracked by Wall St. Rank hold RPTX as of Q1 2021.

  • Schonfeld Strategic Advisors reported no remaining Repare Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 21,200 Repare Therapeutics shares in Q1 2021, an estimated $728K.
  • Schonfeld Strategic Advisors first reported a position in Repare Therapeutics in Q4 2020 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Repare Therapeutics position peaked at $728K in Q4 2020.
  • 65 funds tracked by Wall St. Rank held Repare Therapeutics as of Q1 2021.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2021, filed 17 May 2021.